Gene Expression Profiling of ErbB Receptors and Ligands in Human Meningiomas

REFERENCES

• CBTRUS (Central Brain Tumor Registry of the United States). Statistical reports primary brain tumors in the United States, 1988–2002. CBTRUS, Chicago, IL 2005
   Google Scholar
• Baser M. E., Gareth R. E., Evans R., Gutmann D. H. Neurofibromatosis 2. Cur Opin Neurol 2003; 16: 27–31
   PubMed Web of Science ®Google Scholar
• Szijan I., Rochefort D., Bruder C., Surace E., Machiavelli G., Dalamon V., Cotignola J., Ferreiro V., Campero A., Basso A., Dumanski J., Rouleau G. A. NF2 tumor suppressor gene: a comprehensive and efficient detection of somatic mutations by denaturing HPLC and microarray-CGH. NeuroMol Med 2003; 3: 41–52
   PubMed Web of Science ®Google Scholar
• Wellenreuther R., Kraus J. A., Lenartz D., Menon A. G., Schramm J., Louis D. N., Ramesh V., Gusella J. F., Wiestler O. D., von Deimling A. Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol 1995; 146: 827–832
   PubMed Web of Science ®Google Scholar
• Watson M. A., Gutmann D. H., Peterson K., Chicoine M. R., Kleinschmidt-DeMasters B. K., Brown H. G., Perry A. Molecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays. Am J of Pathol 2002; 161: 665–672
   PubMed Web of Science ®Google Scholar
• Fathallah-Shaykh H. M., He B., Zhao L. J., Engelhard H. H., Cerullo L., Lichtor T., Byrne R., Munoz I., Von Roenn K., Rosseau G. L., Glick R., Sherman C., Farooq K. Genomic expression discovery predicts pathways and opposing functions behind phenotypes. J Biol Chem 2003; 278: 23830–23833
   PubMed Web of Science ®Google Scholar
• Blume-Jensen P., Hunter T. Oncogenic kinase signalling. Nature 2001; 411: 355–365
   PubMed Web of Science ®Google Scholar
• Salomon D. S., Brandt R., Ciardiello F., Normando N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 1995; 19: 183–232
   PubMed Web of Science ®Google Scholar
• Yarden Y., Sliwkowski M. X. Untangling the ErbB signalling network. Nature Rev Mol Cell Biol 2001; 2: 131–141
   Google Scholar
• Amsellem-Ouazana D., Bieche I., Tozlu S., Botto H., Debre B., Lidereau R. Gene expression profiling of ERBB receptors and ligands in human transitional cell carcinoma of the bladder. J Urol 2006; 175: 1127–1132
   PubMed Web of Science ®Google Scholar
• Moasser M. M. The oncogene HER2: its signalling and transforming functions and its role in human cancer pathogenesis. Oncogene 2007; 26: 6469–6487
   PubMed Web of Science ®Google Scholar
• Tzahar E., Pinkas-Kramarski R., Moyer J. D., Klapper L. N., Alroy I., Levkowitz G., Shelly M., Henis S., Eisenstein M., Ratzkin B. J., Sela M., Andrews G. C., Yarden Y. Bivalence of EGF-like ligands drives the ErbB signalling network. EMBO J 1997; 16: 4938–4950
   PubMed Web of Science ®Google Scholar
• Burden S., Yarden Y. Neuregulins and their receptors: a versatile signalling module in organogenesis and oncogenesis. Neuron 1997; 18: 847–855
   PubMed Web of Science ®Google Scholar
• Bieche I., Onody P., Tozlu S., Driouch K., Vidaud M., Lidereau R. Prognostic value of ERBB family mRNA expression in breast carcinomas. Int J Cancer 2003; 106: 758–765
   PubMed Web of Science ®Google Scholar
• Andersson U., Guo D., Malmer B., Bergenheim T., Brännström T., Hedman H., Henriksson R. Epidermal growth factor receptor family (EGFR, ErbB2–4) in gliomas and meningiomas. Acta Neuropahologica 2004; 108: 135–142
   PubMed Web of Science ®Google Scholar
• Loussouarn D., Brunon J., Avet-Loiseau H., Campone M., Mosnier J.-F. Prognostic value of HER2 expression in meningiomas: an immunohistochemical and fluorescence in situ hybridization study. Human Path 2006; 37: 415–421
   PubMed Web of Science ®Google Scholar
• Potti A., Panwalkar A., Langness E., Sholes K., Tendulkar K., Chittajalu S., Koch M. Role of HER-2/neu overexpression and clinical features at presentation as predictive factors in meningiomas. Am J Clin Oncol 2004; 27: 452–456
   PubMed Web of Science ®Google Scholar
• Halper J., Chaeyong J., Perry A., Suliman H., Hill M. P., Scheithauer B. Expression of TGFαin meningiomas. J Neuro-oncol 1999; 45: 127–134
   PubMed Web of Science ®Google Scholar
• Bono J. S., Rowinsky E. K. The ErbB receptor family: a therapeutic target for cancer. Trends Mol Med 2002; 8(4)S19–S2, Suppl.
   PubMed Web of Science ®Google Scholar
• Seidman A. D., Fornier M. N., Esteva F. J., Tan L., Kaptain S., Bach A., Panageas K. S., Arroyo C., Valero V., Currie V., Gilewski T., Theodoulou M., Moynahan M. E., Moasser M., Sklarin N., Dickler M., D'Andrea G., Cristofanilli M., Rivera E., Hortobagyi G. N., Norton L., Hudis C. A. Weekly trastuzumab and paklitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification. J Clin Oncol 2001; 19: 2587–2595
   PubMed Web of Science ®Google Scholar
• Slamon D. J., Leyland-Jones B., Shak S., Fuchs H., Paton V., Bajamonde A., Fleming T., Eiermann W., Wolter J., Pegram M., Baselga J., Norton L. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. New Ingl J Med 2001; 344: 783–792
   PubMed Web of Science ®Google Scholar
• Baselga J., Arteaga C. Critical update and emerging trends in epidermal growth factor receptor targeting in cancer. J Clin Oncol 2005; 23: 2445–2459
   PubMed Web of Science ®Google Scholar
• Conover W. J. Practical Nonparametric Statistics 3rd. John Wiley & Sons. 1999
   Google Scholar
• Roberts P. J., Der C. J. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 2007; 26: 3291–3310
   PubMed Web of Science ®Google Scholar
• Moscatello D. K., Holgado Madruga M., Godwin A. K., Ramirez G., Jun G., Zoltick P. W., Biegel J. A., Hayes R. L., Wong A. J. Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors. Cancer Res 1995; 55: 5536–5539
   PubMed Web of Science ®Google Scholar
• Slamon D. J., Godolphin E., Jones L. A., Holt J. A., Wong S. G., Keith D. E. Studies of the HER-2/neu protooncogene in human breast and ovarian cancer. Science 1989; 244: 707–712
   PubMed Web of Science ®Google Scholar
• Junttila T. T., Laato M., Vablberg T., Söderström, Visacorpi T., Isola J., Elenius K. Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients. Clin Cancer Res 2003; 9: 5346–5357
   PubMed Web of Science ®Google Scholar
• Schlegel J., Ullrich B., Stumm G., Gass P., Harwerth I.-M., Hynes N. E., Kissling M. Expression of the c-erbB-2-encoded oncoprotein and progesterone receptor in human meningiomas. Acta neuropathol 1993; 86: 473–479
   PubMed Web of Science ®Google Scholar
• Chozik B. S., Benzil D. L., Stopa E. G., Pezzullo J. C., Knuckey N. W., Epstein M. H., Finkelstein S. D., Finch P. W. Immunohistochemical evaluation of erb-2 and p53 protein expression in benign and atypical human meningiomas. J Neurooncol 1996; 27: 117–126
   PubMed Web of Science ®Google Scholar
• Kew Y., Bell J. A., Pinder S. E., Denley H., Srinivasan R., Gullick W. J., Nicholson R. I., Blamey R. W., Ellis I. O. ErbB4 protein expression in human breast cancer. Br. J. Cancer 2000; 82: 1163–1170
   PubMed Web of Science ®Google Scholar
• Hartwell L. H., Hopfield J. J., Leibler S., Murray A. W. From molecular to modular cell biology. Nature 1999; 402(Suppl.)C47–C52
   PubMed Web of Science ®Google Scholar
• Ravasz E., Somera A. L., Mongru M. A., Oltvai Z. N., Varabais A. -L. Hierarchical organization of modularity in metabolic networks. Science 2002; 297: 1551–1555
   PubMed Web of Science ®Google Scholar
• Goh K., II, Cusik M. E., Vallet D., Childs B., Vidal M., Barabasi A. -L. The human disease network. Proc Natl Acad Sci USA 2007; 104: 8685–8690
   PubMed Web of Science ®Google Scholar
• Weinstein IB. Cancer; enhanced: addiction to oncogenes—the achiles heal of cancer. Science 2002; 297: 63–64
   PubMed Web of Science ®Google Scholar